Katherine S. Bowdish

3.7k citations

29 papers · 2.8k indexed · 1 hit paper · h-index 25

Molecular Biology top 5%
Biotechnology top 0.5%
Immunology top 5%
Plant Science top 5%
Oncology top 10%

Co-authors: Andrew Hiatt Aaron P. Mitchell Anke Kretz-Rommel Fenghua Qin Toshiaki Maruyama Naveen Dakappagari Shana Frederickson Margaret L. Harbison
Topics: Monoclonal and Polyclonal Antibodies Research (8 papers)Fungal and yeast genetics research (7 papers)Immune Cell Function and Interaction (5 papers)
Cited by: Biotechnology Immunology Molecular Biology
Journals: Nature Cell Proceedings of the National Academy of Sciences
Partner nations: United States Switzerland Netherlands

In The Last Decade

Katherine S. Bowdish

28 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Production of antibodies in transgenic plants

1989 690 citations Andrew Hiatt, Katherine S. Bowdish et al. Nature profile →

Peers

Countries citing papers authored by Katherine S. Bowdish

Since Specialization

Citations

This map shows the geographic impact of Katherine S. Bowdish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine S. Bowdish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine S. Bowdish more than expected).

Fields of papers citing papers by Katherine S. Bowdish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine S. Bowdish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine S. Bowdish. The network helps show where Katherine S. Bowdish may publish in the future.

Co-authorship network of co-authors of Katherine S. Bowdish

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine S. Bowdish. A scholar is included among the top collaborators of Katherine S. Bowdish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine S. Bowdish. Katherine S. Bowdish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics 2008 ·Virology ·(unknown),(unknown),Florence M. Brunel,(unknown),Richard Christian Jensen,John M. Louis,Toshiaki Maruyama,Carole A. Bewley,Katherine S. Bowdish,G. Marius Clore,Philip E. Dawson,Shana Frederickson,Rose G. Mage,Douglas D. Richman,Dennis R. Burton,Michael B. Zwick	45
2	A step-wise approach significantly enhances protein yield of a rationally-designed agonist antibody fragment in E. coli 2008 ·Protein Expression and Purification ·Bing Lin,Mark W. Renshaw,(unknown),Lynette M. Smith,(unknown),Katherine S. Bowdish,Shana Frederickson	20
3	A human antibody against anthrax protective antigen protects rabbits from lethal infection with aerosolized spores 2008 ·Human Antibodies ·Martha A. Wild,Karen M. Kumor,(unknown),Hank Lockman,Katherine S. Bowdish	6
4	Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200 2007 ·Cancer Immunology Immunotherapy ·Amara C. Siva,(unknown),Fenghua Qin,Daniela I. Oltean,Katherine S. Bowdish,Anke Kretz-Rommel	89
5	Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells 2007 ·Journal of Immunological Methods ·Amara C. Siva,Richard Kirkland,Bing Lin,Toshiaki Maruyama,John R. McWhirter,(unknown),Katherine S. Bowdish,(unknown)	28
6	In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models 2007 ·Journal of Immunotherapy ·Anke Kretz-Rommel,Fenghua Qin,Naveen Dakappagari,Ruurd Torensma,Susan J. Faas,Dayang Wu,Katherine S. Bowdish	71
7	Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression 2007 ·Expert Opinion on Biological Therapy ·Anke Kretz-Rommel,Katherine S. Bowdish	36
8	CD200 Expression on Tumor Cells Suppresses Antitumor Immunity: New Approaches to Cancer Immunotherapy 2007 ·The Journal of Immunology ·Anke Kretz-Rommel,Fenghua Qin,Naveen Dakappagari,(unknown),John R. McWhirter,Daniela I. Oltean,Shana Frederickson,Toshiaki Maruyama,Martha A. Wild,(unknown),Dayang Wu,Jeremy P. Springhorn,Katherine S. Bowdish	141
9	Internalizing Antibodies to the C-Type Lectins, L-SIGN and DC-SIGN, Inhibit Viral Glycoprotein Binding and Deliver Antigen to Human Dendritic Cells for the Induction of T Cell Responses 2006 ·The Journal of Immunology ·Naveen Dakappagari,Toshiaki Maruyama,Mark W. Renshaw,Paul J. Tacken,Carl G. Figdor,Ruurd Torensma,Martha A. Wild,Dayang Wu,Katherine S. Bowdish,Anke Kretz-Rommel	39
10	Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation 2006 ·Proceedings of the National Academy of Sciences ·John R. McWhirter,Anke Kretz-Rommel,Alan Saven,Toshiaki Maruyama,Kathleen N. Potter,C. Ian Mockridge,(unknown),Fenghua Qin,Katherine S. Bowdish	130
11	Bioactivation of carbamate-based 20(S)-camptothecin prodrugs 2004 ·Bioorganic & Medicinal Chemistry ·Neta Pessah,(unknown),Marina Shamis,Ferda Yantiri,(unknown),Katherine S. Bowdish,Noam Shomron,Gil Ast,Doron Shabat	43
12	Human antibodies from immunized donors are protective against anthrax toxin in vivo 2003 ·Nature Biotechnology ·Martha A. Wild,Hong Xin,Toshiaki Maruyama,(unknown),(unknown),John D. Malone,Mark R. Wallace,Katherine S. Bowdish	82
13	Two Human cDNAs, Including a Homolog of Arabidopsis FUS6 ( COP11 ), Suppress G-Protein- and Mitogen-Activated Protein Kinase-Mediated Signal Transduction in Yeast and Mammalian Cells 1996 ·Molecular and Cellular Biology ·(unknown),Katherine S. Bowdish,(unknown),(unknown),(unknown),Richard Chang,Weilin Xie,John Colicelli	101
14	Positive Control of Yeast Meiotic Genes by the Negative Regulator UME6 1995 ·Molecular and Cellular Biology ·Katherine S. Bowdish,(unknown),Aaron P. Mitchell	87
15	Analysis of RIM11, a yeast protein kinase that phosphorylates the meiotic activator IME1. 1994 ·Molecular and Cellular Biology ·Katherine S. Bowdish,Huanhuan Yuan,Aaron P. Mitchell	69
16	Analysis of RIM11, a Yeast Protein Kinase That Phosphorylates the Meiotic Activator IME1 1994 ·Molecular and Cellular Biology ·Katherine S. Bowdish,(unknown),Aaron P. Mitchell	37
17	Selection for early meiotic mutants in yeast. 1992 ·Genetics ·Aaron P. Mitchell,Katherine S. Bowdish	33
18	Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations 1991 ·Cell ·Pamela L. Schwartzberg,Alan M. Stall,Jeff Hardin,Katherine S. Bowdish,(unknown),Sharon Boast,Margaret L. Harbison,Elizabeth J. Robertson,Stephen P. Goff	290
19	Production of antibodies in transgenic plantsbreakdown → 1989 ·Nature ·Andrew Hiatt,(unknown),Katherine S. Bowdish	690
20	Insect Tolerant Transgenic Tomato Plants 1987 ·Nature Biotechnology ·David A. Fischhoff,Katherine S. Bowdish,Frederick J. Perlak,Pamela G. Marrone,Sheila McCormick,(unknown),(unknown),(unknown),Ernest Mayer,Dean E. Rochester,Stephen G. Rogers,Robert T. Fraley	294

About Katherine S. Bowdish

Katherine S. Bowdish is a scholar working on Physiology, Immunology and Neurology, having authored 29 papers that have together received 2.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Fungal and yeast genetics research (7 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Biotechnology (798 citations), Immunology (755 citations) and Molecular Biology (1.9k citations). Katherine S. Bowdish has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Andrew Hiatt, Aaron P. Mitchell, Anke Kretz-Rommel, Fenghua Qin, Toshiaki Maruyama, Naveen Dakappagari, Shana Frederickson, Margaret L. Harbison, Pamela L. Schwartzberg and Jeff Hardin. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact